Stockscreener 앱 받기
0.4274
15.38%
-0.0777
시간 외 거래:
.42
-0.0074
-1.73%
Karyopharm Therapeutics Inc (KPTI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
4.66%
33.43
|
35.07 | 34.08 | 44.04 | 37.93 |
Operating Expenses
|
9.49%
55.96
|
61.83 | 51.92 | 59.26 | 62.32 |
| Operating Income/Loss |
15.82%
-22.53
|
-26.76 | -17.84 | -15.22 | -24.39 |
| Nonoperating Income/Loss |
1,118%
-44.50
|
4.369 | -84.42 | -17.87 | -12.82 |
| Income/Loss From Continuing Operations Before Tax |
199.33%
-67.02
|
-22.39 | -102.27 | -33.09 | -37.21 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.001 | -0.067 | 0.034 | 0.04 |
| Net Income/Loss |
199.32%
-67.02
|
-22.39 | -102.20 | -33.13 | -37.25 |
| Basic Average Shares |
31.45%
0.0289
|
0.022 | 0.00235 | 0.00867 | 0.00862 |
| Diluted Average Shares |
17.09%
0.0289
|
0.0247 | 0.00235 | 0.00867 | 0.00862 |
| Basic Earnings Per Share |
127.45%
-2.32
|
-1.02 | -7.00 | -3.82 | -4.32 |
| Diluted Earnings Per Share |
87.10%
-2.32
|
-1.24 | -7.00 | -3.82 | -4.32 |
4.80%
자본화:
|
볼륨(24시간):